Last updated: 2026-10-19 20:02:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
LeMaitre Vascular, Inc. (LMAT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $82.30, with a market capitalization of $1.85B and a P/E ratio of 28.14. Over the past 52 weeks, its price has ranged from $78.22 to $118.01. This page covers its latest market performance, valuation, price trends and company information.
$1.85B | |
$81.02 | |
$118.01 | |
$1.54 | |
$80.82 | |
199.00K | |
330.75K | |
28.14 | |
$118.01 | |
$78.22 | |
1.11% | |
-- |
LeMaitre Vascular, Inc. (LMAT) is trading at $82.30 in after-hours trading as of 2026-10-19 20:01:00, up 1.83% ($1.48) from the regular-session close of $80.82.
After-hours trading shows how investors are pricing LMAT after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, LeMaitre Vascular, Inc. (LMAT) moved from $79.64 to $82.30, representing a gain of 3.35% ($2.66).
The stock traded between $78.31 and $84.66 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 261.54 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 10.3%
LMAT is currently trading at $82.30, placing it 10.3% of the way from its 52-week low of $78.22 to its 52-week high of $118.01. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 655 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of LeMaitre Vascular, Inc. (LMAT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.